Replacement therapy with imiglucerase for type 1 Gaucher's disease
- 1 June 1995
- journal article
- Published by Elsevier in The Lancet
- Vol. 345 (8963), 1479-1480
- https://doi.org/10.1016/s0140-6736(95)91038-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant SourcesAnnals of Internal Medicine, 1995
- Low-dose enzyme replacement therapy for Gaucher's disease: Effects of age, sex, genotype, and clinical features on response to treatmentThe American Journal of Medicine, 1994
- Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patientsBlood, 1993
- Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 monthsBlood, 1993
- A Less Costly Regimen of Alglucerase to Treat Gaucher's DiseaseNew England Journal of Medicine, 1992
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991
- PREDICTION OF SEVERITY OF GAUCHER'S DISEASE BY IDENTIFICATION OF MUTATIONS AT DNA LEVELThe Lancet, 1989